ISIS 329993: Clinical Trials

2 trials of ISIS 329993, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow ISIS 329993: new trials by email Literature Review of ISIS 329993 trials Research Report on ISIS 329993

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation
ISIS CRP Rx, Placebo - Paroxysmal Atrial Fibrillation
Phase 2CompletedIonis Pharmaceuticals, Inc.72012-10-012015-08-26
Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis
ISIS CRP Rx or Placebo - Rheumatoid Arthritis
Phase 2CompletedIonis Pharmaceuticals, Inc.512011-08-012013-05-17

Conditions studied

Arthritis, Rheumatoid (1)  ·  Atrial Fibrillation (1)

Sponsors

Ionis Pharmaceuticals, Inc. (2)

Countries

Canada (1)  ·  Russia (1)  ·  United Kingdom (1)

Results publications

PMID 25885521